Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.54 |
| ▸ | TMEM97 | Q5BJF2 | 2/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | HTR7 | P34969 | 1/20 | 0.37 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.33 |
| ▸ | APP | P05067 | 1/20 | 0.33 |
| ▸ | F10 | P00742 | 1/20 | 0.33 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | NAMPT | P43490 | 3/20 | 0.32 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18395905 | 1.00 | CA2 (0.54) | CA2TMEM97SIGMAR1ALDH1A1NPSR1 | |
| SCHEMBL6943821 | 0.87 | CA2 (0.56) | CA2TMEM97SIGMAR1ALDH1A1NPSR1 | |
| SCHEMBL461346 | 0.87 | CA2 (0.56) | CA2TMEM97SIGMAR1ALDH1A1NPSR1 | |
| SCHEMBL18395904 | 0.87 | CA2 (0.56) | CA2TMEM97SIGMAR1ALDH1A1NPSR1 | |
| SCHEMBL6575404 | 0.87 | CA2 (0.56) | CA2TMEM97SIGMAR1ALDH1A1NPSR1 | |
| SCHEMBL7042451 | 0.87 | CA2 (0.49) | CA2TMEM97SIGMAR1ALDH1A1NPSR1 | |
| SCHEMBL15226054 | 0.86 | CA2 (0.54) | CA2TMEM97SIGMAR1ALDH1A1NPSR1 | |
| SCHEMBL15225845 | 0.86 | CA2 (0.54) | CA2TMEM97SIGMAR1ALDH1A1NPSR1 | |
| SCHEMBL15225887 | 0.86 | CA2 (0.54) | CA2TMEM97SIGMAR1ALDH1A1NPSR1 | |
| SCHEMBL12513225 | 0.84 | CA2 (0.53) | CA2TMEM97SIGMAR1ALDH1A1NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118304295-A | Pharmaceutical composition of endothelin A (ETA) receptor antagonist compound and application thereof | 深圳信立泰药业股份有限公司 | 2024-07-09 | — | — | CN | disclosed |
| WO-2024022262-A1 | SALT OF ENDOTHELIN A (ETA) RECEPTOR ANTAGONIST COMPOUND, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF | 深圳信立泰药业股份有限公司 | 2024-02-01 | — | — | WO | disclosed |
| CN-117447453-A | Pharmaceutically acceptable salt crystal forms of endothelin A (ETA) receptor antagonist compounds and preparation method thereof | 深圳信立泰药业股份有限公司 | 2024-01-26 | — | — | CN | disclosed |
| CN-116194449-A | Endothelin A (ETA) receptor antagonist compound and preparation method and medical application thereof | 深圳信立泰药业股份有限公司 | 2023-05-30 | — | — | CN | disclosed |
| EP-0973768-B1 | AZOLE COMPOUNDS, THEIR PRODUCTION AND THEIR USE | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 2003-07-09 | — | — | EP | disclosed |
| US-6583164-B1 | Lyophilized imidazole-1-yl or 1,2,4-triazole-1-yl quaternized with a alklycarbonyloxy alkyl group eliminated in vivo; a saccharide; 4-acetoxymethyl-1-(3-(2-oxo-3-(4-(1H-tetrazol-yl) phenyl)-1-imidazolydinyl)butyl)-1H-1,2,4-triazolium chloride | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2003-06-24 | — | — | US | disclosed |
| US-6407129-B1 | INJECTABLE QUATERNIZED SALT FUNGICIDES; WATER SOLUBILITY | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2002-06-18 | — | — | US | disclosed |
| EP-1120116-A1 | ANTIMYCOTIC DRUG COMPOSITION | Takeda Chemical Industries, Ltd. (JP) | 2001-08-01 | — | — | EP | disclosed |